Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values-Reference-Cited by-同舟云学术

Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

Published:2014-06-21 Issue:1-2 Volume:178 Page:1-9
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Castanheira Mariana,Messer Shawn A.,Rhomberg Paul R.,Dietrich Rachel R.,Jones Ronald N.,Pfaller Michael A.

Publisher

Springer Science and Business Media LLC

Subject

Veterinary (miscellaneous),Agronomy and Crop Science,Applied Microbiology and Biotechnology,Microbiology,Plant Science,Agricultural and Biological Sciences (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s11046-014-9772-2.pdf

Reference47 articles.

1. Ha YE, Peck KR, Joo EJ, et al. Impact of first-line antifungal agents on the outcomes and costs of candidemia. Antimicrob Agents Chemother. 2012;56:3950–6.

2. Lepak A, Andes D. Fungal sepsis: optimizing antifungal therapy in the critical care setting. Crit Care Clin. 2011;27:123–47.

3. Pakyz AL, Gurgle HE, Oinonen MJ. Antifungal use in hospitalized adults in U.S. academic health centers. Am J Health Syst Pharm. 2011;68:415–8.

4. Posteraro B, Posteraro P, Sanguinetti M. Update on antifungal resistance and its clinical impact. Curr Fungal Infect Rep. 2013; (in press).

5. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens;Medical Mycology;2024-06

2. Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity;Mycoses;2023-07-11

3. Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates;Mycopathologia;2022-12-10

4. Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms;Brazilian Journal of Microbiology;2022-10-28

5. Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against Candida glabrata;Journal of Fungi;2022-05-20